RANKL has been implicated in the development of progestin-induced breast cancer in mice, through a mechanism similar to the physiological progesterone-mediated epithelial cell proliferation occurring in the mammary gland [17,18]. This evidence concerns the gene TNFSF11 and breast carcinoma.